Microenvironmental modulation in tandem with human stem cell transplantation enhances functional recovery after chronic complete spinal cord injury. (April 2023)
- Record Type:
- Journal Article
- Title:
- Microenvironmental modulation in tandem with human stem cell transplantation enhances functional recovery after chronic complete spinal cord injury. (April 2023)
- Main Title:
- Microenvironmental modulation in tandem with human stem cell transplantation enhances functional recovery after chronic complete spinal cord injury
- Authors:
- Hashimoto, Shogo
Nagoshi, Narihito
Shinozaki, Munehisa
Nakanishi, Katsuyuki
Suematsu, Yu
Shibata, Takahiro
Kawai, Momotaro
Kitagawa, Takahiro
Ago, Kentaro
Kamata, Yasuhiro
Yasutake, Kaori
Koya, Ikuko
Ando, Yoshinari
Minoda, Aki
Shindo, Tomoko
Shibata, Shinsuke
Matsumoto, Morio
Nakamura, Masaya
Okano, Hideyuki - Abstract:
- Abstract: While rapid advancements in regenerative medicine strategies for spinal cord injury (SCI) have been made, most research in this field has focused on the early stages of incomplete injury. However, the majority of patients experience chronic severe injury; therefore, treatments for these situations are fundamentally important. Here, we hypothesized that environmental modulation via a clinically relevant hepatocyte growth factor (HGF)-releasing scaffold and human iPS cell-derived neural stem/progenitor cells (hNS/PCs) transplantation contributes to functional recovery after chronic complete transection SCI. Effective release of HGF from a collagen scaffold induced progressive axonal elongation and increased grafted cell viability by activating microglia/macrophages and meningeal cells, inhibiting inflammation, reducing scar formation, and enhancing vascularization. Furthermore, hNS/PCs transplantation enhanced endogenous neuronal regrowth, the extension of graft axons, and the formation of circuits around the lesion and lumbar enlargement between host and graft neurons, resulting in the restoration of locomotor and urinary function. This study presents an effective therapeutic strategy for severe chronic SCI and provides evidence for the feasibility of regenerative medicine strategies using clinically relevant materials.
- Is Part Of:
- Biomaterials. Volume 295(2023)
- Journal:
- Biomaterials
- Issue:
- Volume 295(2023)
- Issue Display:
- Volume 295, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 295
- Issue:
- 2023
- Issue Sort Value:
- 2023-0295-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-04
- Subjects:
- Spinal cord transection injury -- Chronic phase -- iPS cell -- Cell transplantation therapy -- Scaffold -- Hepatocyte growth factor
spinal cord injury SCI -- hepatocyte growth factor HGF -- human iPS cell-derived neural stem/progenitor cells hNS/PCs -- pelnac G plus PGp -- adeno-associated virus AAV -- wheat germ agglutinin WGA
Biomedical materials -- Periodicals
Biocompatible Materials -- Periodicals
Biomatériaux -- Périodiques
610.28 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01429612 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01429612 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01429612 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.biomaterials.2023.122002 ↗
- Languages:
- English
- ISSNs:
- 0142-9612
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2087.715000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26093.xml